Zepzelca (lurbinectedin)

pCPA File Number: 22128
Negotiation Status:
Under consideration for negotiation
Indication(s):
For the treatment of adult patients with Stage III or metastatic small cell lung cancer (SCLC) who have progressed on or after platinum-containing therapy
Sponsor/Manufacturer:
Jazz Pharmaceuticals Canada Inc.
CADTH Project Number:
PC0281
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable